Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2025

Jul 2, 2025

34472_dirs_2025-07-02_f3c4de04-d2f8-489a-aa76-07dfbc4e2e45.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2025-07-01

Reporting Person: MASSARANY HANY (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-01 Common Stock M 26368 Acquired 310135 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-07-01 Restricted Stock Units $ M 26368 Disposed Common Stock (26368) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 53364 Indirect

Footnotes

F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2: Mr. Massarany is a trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein.

F3: These fully vested RSUs settled on July 1, 2025, and had no expiration date.